Rossella Ciurleo

Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial

N. Bresolin, V. Torri, R. Pallini, 2022, The Lancet Neurology.

Nabiximols plus robotic assisted gait training in improving motor performances in people with Multiple Sclerosis.

R. Calabró, A. Naro, M. Russo, 2020, Multiple sclerosis and related disorders.